De Swart, R. L., El Mubarak, H. S., Vos, H. W., Mustafa, O. M., Abdallah, A., Groen, J., Mukhtar, M. M., Zijlstra, E. E., El Hassan, A. M., Wild, T. F., Ibrahim, S. A., and Osterhaus, A. D. Prevention of measles in Sudan: a prospective study on vaccination, diagnosis and epidemiology Vaccine. 3212001, 19 (1719): 22542257. Desguerre I, Ponsot G. Hepatitis B vaccination and neurologic manifestations in children. Arch Pediatr. 2001 May; 8 Suppl 2:325s326s. DeStefano, F. and Chen, R. T. Autism and measlesmumpsrubella vaccination: controversy laid to rest? CNS.Drugs. 2001, 15 (11): 831837. DeStefano, F. More evidence to reassure physicians and parents about vaccination West J.Med. 2001, 174 (6): 390391. DeWilde, S., Carey, I. M., Richards, N., Hilton, S. R., and Cook, D. G. Do children who become autistic consult more often after MMR vaccination? Br.J.Gen.Pract. 2001, 51 (464): 226227. DiezDomingo, J., Pereiro, I., Morant, A., Gimeno, C., San Martin, M., and Gonzalez, A. Impact of nonroutine vaccination on the incidence of invasive Haemophilus influenzae type b (Hib) disease: experience in the autonomous region of Valencia, Spain J.Infect. 2001, 42 (4): 257260. Dionne, M., Boulianne, N., Duval, B., Lavoie, F., Laflamme, N., Carsley, J., Valiquette, L., Gagnon, S., Rochette, L., and De Serres, G. [Lack of conviction about vaccination in certain Quebec vaccinators] Can.J.Public Health. 2001, 92 (2): 100104. Donnelly S, Loscher CE, Lynch MA, Mills KH. Wholecell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxininduced interleukin1beta in a new murine model for analysis of neuronal side effects of vaccination. Infect Immun 2001 Jul;69(7):421723. Downes, K. A., Domen, R. E., McCarron, K. F., and Bringelsen, K. A. Acute autoimmune hemolytic anemia following DTP vaccination: report of a fatal case and review of the literature Clin.Pediatr.(Phila). 2001, 40 (6): 355358. Doyle, daNM, Dauterive, R., Chuang, K. H., and Ellrodt, A. G. Translating evidence into practice: pursuing perfection in pneumococcal vaccination in a rural community Respir.Care. 2001, 46 (11): 12581275. Earhart, K. C., Beadle, C., Miller, L. K., Pruss, M. W., Gray, G. C., Ledbetter, E. K., and Wallace, M. R. Outbreak of influenza in highly vaccinated crew of u.s. navy ship Emerg.Infect.Dis. 2001, 7 (3): 463465. Eason, E., Naus, M., Sciberras, J., and Oppenheimer, L. Evaluation of an institutionbased protocol for postpartum rubella vaccination CMAJ. 11132001, 165 (10): 13211323. Edmunds, W. J., Gay, N. J., Henao Restrepo, A. M., Olive, J., and Bele, O. Measles vaccination in Africa: by how much could routine coverage be improved? Vaccine. 10122001, 20 (12): 1618. Effectiveness of influenza vaccination in the elderly in a community in Italy Eur.J.Epidemiol. 2001, 17 (2): 163168. Egemen, A., Aksit, S., Ozacar, T., Kurugol, Z., Keskinoglu, P., Pehlivan, T., and Mutlu, S. Measles seroprevalence in Izmir with special emphasis on measles vaccination policy for Turkey Pediatr.Int. 2001, 43 (4): 379384. Eicken C, Sharma V, Klabunde T, Owens RT, Pikas DS, Hook M, Sacchettini JC. Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi. J Biol Chem 2001 Jan 3; El Kasmi, K. C. and Muller, C. P. New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules Vaccine. 3212001, 19 (1719): 22382244. Engers, H. D. [AntiMalarial Vaccination Today]. Bull Soc Pathol Exot; 94 (2 Pt 2): 147148; July, 2001. Ernst, E. Rise in popularity of complementary and alternative medicine: reasons and consequences for vaccination Vaccine. 10152001, 20 Suppl 1:S903. (): S90S93. Exner, M. Successful vaccination for Lyme disease: a novel mechanism? Expert Opin Biol Ther 2001; 1(5): 78393. Faustini, A., Franco, E., Sangalli, M., Spadea, T., Calabrese, R. M., Cauletti, M., and Perucci, C. A. Persistence of antiHBs 5 years after the introduction of routine infant and adolescent vaccination in Italy Vaccine. 462001, 19 (2022): 28122818. Feldman, R. Group B Streptococcus. Prevention of Infection in the Newborn Pract.Midwife. 2001, 4 (3): 1618. Fiechtner, H. B. and Falls, S. Vaccination myths and misconceptions S D.J.Med. 2001, 54 (5): 165166. Finsterer J, Artner C, Kladosek A, Kalchmayr R, Redtenbacher S. Cavernous sinus syndrome due to vaccinationinduced giant cell arteritis. Arch Intern Med. 2001 Apr 9;161(7):10089. Finsterer, J., Artner, C., Kladosek, A., Kalchmayr, R., and Redtenbacher, S. Comments, Opinions and Brief Case Reports: Cavernous Sinus Syndrome Due to VaccinationInduced Giant Cell Arteritis Arch.Intern.Med. 492001, 161 (7): 10081009. Fisher MA, Eklund SA, James SA, Lin X. Adverse events associated with hepatitis B vaccine in U.S. children less than six years of age, 1993 and 1994. Ann Epidemiol 2001 Jan;11(1):1321. Fjallbrant, H., Ridell, M., and Larsson, L. O. The tuberculin skin test in reaction to immunological in vitro reactions in BCGvaccinated healthcare workers Eur.Respir.J. 2001, 18 (2): 376380. Folb, P. I. Routine vaccination and child survival in GuineaBissau. WHO responds to GuineaBissau report BMJ. 2102001, 322 (7282): 361. Fulton, J. P. Asthma and flu vaccination Med.Health R.I. 2001, 84 (10): 343. Funada, H. and Abe, Y. [Twostep tuberculin testing and BCG vaccination in the personnel of a medical and pharmaceutical university] Kekkaku. 2001, 76 (8): 563569. Gaillat, J. and Leophonte, P. [Pneumococcal vaccination: renewed awarness?] Rev.Pneumol.Clin. 2001, 57 (1): 35. Gans, H., Yasukawa, L., Rinki, M., DeHovitz, R., F<strong>org</strong>hani, B., Beeler, J., Audet, S., Maldonado, Y., and Arvin, A. M. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months J.Infect.Dis. 1012001, 184 (7): 817826. GarciaDoval, I., Roson, E., Feal, C., De la, Torre C., Rodriguez, T., and Cruces, M. J. Generalized bullous fixed drug eruption after influenza vaccination, simulating bullous pemphigoid Acta Derm.Venereol. 2001, 81 (6): 450451. Gardner, E. M., Bernstein, E. D., Dran, S., Munk, G., Gross, P., Abrutyn, E., and Murasko, D. M. Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population Vaccine. 9142001, 19 (32): 46104617. Garly, M. L., Bale, C., Martins, C. L., Balde, M. A., Hedegaard, K. L., Whittle, H. C., and Aaby, P. BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheriatetanus antigens Vaccine. 11122001, 20 (34): 468474. GasiorChrzan, B. Delayed granulomatous lesion at the bacillus CalmetteGuerin vaccination site Acta Derm.Venereol. 2001, 81 (4): 302304. Ge<strong>org</strong>eChandy, A., Mielcarek, N., Nordstrom, I., Holmgren, J., and Eriksson, K. Vaccination with Bordetella pertussisPulsed Autologous or Heterologous Dendritic Cells Induces a Mucosal Antibody Response In Vivo and Protects against Infection Infect.Immun. 2001, 69 (6): 41204124. Ge<strong>org</strong>itis, J. W. and Fasano, M. B. Allergenic components of vaccines and avoidance of vaccinationrelated adverse events Curr.Allergy Rep. 2001, 1 (1): 11 17. Ghani, S. Convincing an Asian Community of the Importance of Flu Vaccination Prof.Nurse 2001, 17 (2): 130. Ghosh, C. Periorbital and orbital cellulitis after H. influenza B vaccination Ophthalmology. 2001, 108 (9): 15141515. Goronzy, J. J., Fulbright, J. W., Crowson, C. S., Poland, G. A., O'Fallon, W. M., and Weyand, C. M. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals J.Virol. 2001, 75 (24): 1218212187. Gout O. Vaccinations and multiple sclerosis. Neurol Sci 2001 Apr;22(2):1514. Griffin, J. P. MMR vaccination: how reassuring is reassurance? Adverse Drug React.Toxicol.Rev. 2001, 20 (1): 12. Grime, P. BCG revaccination Thorax. 2001, 56 (9): 741742. Gutierrez, E. B., Li, H. Y., Santos, A. C., and Lopes, M. H. Effectiveness of influenza vaccination in elderly outpatients in Sao Paulo city, Brazil Rev.Inst.Med.Trop.Sao Paulo. 2001, 43 (6): 317320. Hall, G. H. Antiflu, or antideath vaccination? Lancet. 6302001, 357 (9274): 2141. Hamilton, M. The MMR vaccination and autism: a lay person's contribution West Indian Med.J. 2001, 50 (1): 8789. Handjani, F., Delir, S., Sodaifi, M., and Kumar, P. V. Lupus vulgaris following bacille CalmetteGuerin vaccination Br.J.Dermatol. 2001, 144 (2): 444445.
Hanna, J. N., Young, D. M., Brookes, D. L., Dostie, B. G., and Murphy, D. M. The initial coverage and impact of the pneumococcal and influenza vaccination program for atrisk indigenous adults in Far North Queensland Aust.N.Z.J.Public Health. 2001, 25 (6): 543546. Harel Z, Ipp L, Riggs S, Vaz R, Flanagan P. Serotesting versus presumptive varicella vaccination of adolescents with a negative or uncertain history of chickenpox. J Adolesc Health 2001 Jan;28(1):269 Hassler, D., Braun, R., and Kimmig, P. [Vaccinations. Meningococci] Dtsch.Med.Wochenschr. 1272001, 126 (49): A1120. Havinga, W. Vaccinations as risk factors for wheezing disorders Lancet. 1062001, 358 (9288): 1186. Hedlund, J., Langer, B., Konradsen, H. B., and Ortqvist, A. Negligible adjuvant effect for antibody responses and frequent adverse events associated with IL 12 treatment in humans vaccinated with pneumococcal polysaccharide Vaccine. 10122001, 20 (12): 164169. Heller, D. Ethical debate: Vaccination against mumps, measles, and rubella: is there a case for deepening the debate? How safe is MMR vaccine? BMJ. 1013 2001, 323 (7317): 839840. HernandezSuarez, C. M. A note on the distribution of the number of vaccinated infected under nonrandom mixing conditions Stat.Med. 7152001, 20 (13): 19831986. Herrera, G. A., Zhao, Z., and Klevens, R. M. Variation in vaccination coverage among children of Hispanic ancestry(2) Am.J.Prev.Med. 2001, 20 (4 Suppl): 6974. Heyderman, R. Commentary: Should programmes for communitylevel meningococcal vaccination be considered in Australiaan economic evaluation Int.J.Epidemiol. 2001, 30 (3): 578579. Higson, N. Health professionals' attitudes to MMR vaccine. Doctors must understand reasons behind vaccination BMJ. 552001, 322 (7294): 1121. Hodge, J. G.; Gostin, L. O. School Vaccination Requirements: Historical, Social, and Legal Perspectives. KY Law J; 90 (4): 831890; 2001. Hoglund, D. and Stenqvist, K. [More elderly persons should be informed about the importance of vaccination against influenza. Extensive needs of information also among the health personnel] Lakartidningen. 1172001, 98 (3): 156158. Holdiness, M. R. Adverse cutaneous reactions to influenza vaccinations and chemotherapy Int.J.Dermatol. 2001, 40 (7): 427430. HouckeBruge, C., Delaporte, E., Catteau, B., Martin, De Lassalle, and Piette, F. [Granuloma annulare following BCG vaccination] Ann.Dermatol.Venereol. 2001, 128 (4): 541544. Howe, M. Pneumoccocal vaccination programme begins in Australia Lancet Infect.Dis. 2001, 1 (2): 69. Hull, H. F. The future of polio eradication Lancet Infect.Dis. 2001, 1 (5): 299303. Humiston, S. G. and Strikas, R. A. Routine childhood vaccination update: educating the office staff Pediatr.Ann. 2001, 30 (6): 329341. Hutchins, S. S., Dezayas, A., Blond, K. L., Heath, J., Bellini, W., Audet, S., Beeler, J., Wattigney, W., and Markowitz, L.Evaluation of an Early TwoDose Measles Vaccination Schedule. Am J Epidemiol 2001; 154(11): 10641071. Ii, M. and Ohkusa, Y. [An empirical research for demand of influenza vaccination] Nippon Koshu Eisei Zasshi. 2001, 48 (1): 1627. Immunological response to influenza vaccination in children with renal failure Nephrol.Dial.Transplant. 2001, 16 (3): 643644. Iwane, M. K. and Schwartz, B. Pediatric influenza immunization: should healthy children be vaccinated? Pediatr.Ann. 2001, 30 (6): 354357. Jacobson, R. M., Adegbenro, A., Pankratz, V. S., and Poland, G. A. Adverse events and vaccinationthe lack of power and predictability of infrequent events in prelicensure study Vaccine. 3212001, 19 (1719): 24282433. Jefferys, R. T cells and vaccination Lancet. 552001, 357 (9266): 1451. Jha, N., Kannan, A.T., Paudel, I.S., Niraula, S. EPI vaccination in Nepal. Southeast Asian J Trop Med Public Health. 2001 Sep;32(3):54752. Johansson, E. L., Wassen, L., Holmgren, J., Jertborn, M., and Rudin, A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans Infect.Immun. 2001, 69 (12): 74817486. Johnson, A. and Joynes, E. V. MMR vaccination uptake in a rural setting Br.J.Gen.Pract. 2001, 51 (466): 408. JonvilleBera, A. P., AutretLeca, E., Barbeillon, F., and Llado, J. P. [Relationship between vaccination for diphtheriatetanuspertussis +/ Haemophilus influenzae b and sudden infant death before three months of age: a casecontrol study] Arch.Pediatr. 2001, 8 (11): 12721273. JonvilleBera, A. P., AutretLeca, E., Barbeillon, F., and ParisLlado, J. Sudden unexpected death in infants under 3 months of age and vaccination status a casecontrol study Br.J.Clin.Pharmacol. 2001, 51 (3): 271276. Juretzko, P., FabianMarx, T., Haastert, B., Giani, G., von Kries, R., and Wirsing von Konig, C. H. Kaji, M., Tsuru, T., and Oizumi, K. [Efficacy and safety of influenza vaccination to elderly patients with neurological diseases] Kansenshogaku Zasshi. 2001, 75 (5): 411415. Kakurai, M., Kiyosawa, T., Ohtsuki, M., and Nakagawa, H. Multiple lesions of granuloma annulare following BCG vaccination: case report and review of the literature. Int J Dermatol 2001; 40(9): 579581. Kalinowski, P. The influence of prophylactic vaccination on epidemic situation of infectious diseases illustrated by the epidemiology of measles in Poland in the years 19681998. Ann Univ Mariae Curie Sklodowska [Med]. 2001;56:32732. KanakoudiTsakalidou, F., Trachana, M., PratsidouGertsi, P., Tsitsami, E., and KyriazopoulouDalaina, V. Influenza vaccination in children with chronic rheumatic diseases and longterm immunosuppressive therapy Clin.Exp.Rheumatol. 2001, 19 (5): 589594. Keiholz, U., Scheibenbogen, C., Theil, E., and Schadendorf, D. Rational development of peptide vaccination in clinical oncology Onkologie. 2001, 24 (2): 174. Kent, S. J., Dale, C. J., Preiss, S., Mills, J., Campagna, D., and Purcell, D. F. Vaccination with attenuated simian immunodeficiency virus by DNA inoculation J.Virol. 2001, 75 (23): 1193011934. Khalfan SA, Chomel JJ, Mallet L, Fernandes E, Lahlou AI, Lina B, Aymard M. Paralytic poliomyelitis associated with the Sabin 3 revertant strain of poliovirus in Bahrain. Ann Trop Paediatr 2001 Sep;21(3):2239. Khalil, M. K.; Al Mazrou, Y. Y.; Al Jeffri, M.; Al Ghamdy, Y. S. Measles Immunization in Saudi Arabia: the Need for Change. East Mediterr.Health J. 7 (4 5): 829834; July, 2001. Kharabsheh, S., Al Otoum, H., Clements, J., Abbas, A., KhuriBulos, N., Belbesi, A., Gaafar, T., and Dellepiane, N. Mass psychogenic illness following tetanusdiphtheria toxoid vaccination in Jordan Bull.World Health Organ. 2001, 79 (8): 764770. Khetsuriani, N., Bisgard, K., Prevots, D. R., Brennan, M., Wharton, M., Pandya, S., Poppe, A., Flora, K., Dameron, G., and Quinlisk, P. Pertussis outbreak in an elementary school with high vaccination coverage. Pediatr Infect Dis J 2001; 20(12): 11081112. Kim, J., Jeong, E., Lee, J., Yang, S., Shin, Y., Yoon, Y., and Chun, B. C. A WebBased Interactive Education Programme on Vaccination for Public Health Officials Asia Pac.J.Public Health 2001, 13 Suppl:S712. (): S712. Kimball, P., Verbeke, S., and Tolman, D. Influenza vaccination among heart transplant recipients Transplant.Proc. 2001, 33 (12): 17851786. Klugman, K. P. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance Lancet Infect.Dis. 2001, 1 (2): 8591. Konstantinou D, Paschalis C, Maraziotis T, Dimopoulos P, Bassaris H, Skoutelis A. Two episodes of leukoencephalitis associated with recombinant hepatitis b vaccination in a single patient. Clin Infect Dis 2001 Nov 15;33(10):17723. Kovarik, J. and Siegrist, C. A. The search for novel adjuvants for early life vaccinations: can "danger" motifs show us the way? Arch.Immunol.Ther.Exp.(Warsz.). 2001, 49 (3): 209215. Kramarz, P., Destefano, F., Gargiullo, P. M., Chen, R. T., Lieu, T. A., Davis, R. L., Mullooly, J. P., Black, S. B., Shinefield, H. R., Bohlke, K., Ward, J. I., and Marcy, S. M. Does influenza vaccination prevent asthma exacerbations in children? J.Pediatr. 2001, 138 (3): 306310. Kramarz, P., France, E. K., DeStefano, F., Black, S. B., Shinefield, H., Ward, J. I., Chang, E. J., Chen, R. T., Shatin, D., Hill, J., Lieu, T., and Ogren, J. M. Populationbased study of rotavirus vaccination and intussusception Pediatr.Infect.Dis.J. 2001, 20 (4): 410416. Kreager, A. M.; Cicerone, J.; Hella, S.; Johnson, A. N.; Matthews, L.; Richards, N. L.; Sinishtaj, L.; Tobin, A.; Veltigian, S. A Case Management Approach to Immunizing Patients at High Risk for Influenza. Lippincotts Case Manag; 6 (4): 138142; July, 2001.
- Page 1 and 2: BIBLIOGRAFIA SUI DANNI DA VACCINI A
- Page 3 and 4: Alter HJ, Scanlon RT, Schechter GP.
- Page 5 and 6: Cherry, JD, et al. A Clinical and S
- Page 7 and 8: Kazarian EL, Gager WE. Optic neurit
- Page 9 and 10: Coplan J. Seizures following immuni
- Page 11 and 12: Ipp MM, Gold R, Greenberg S, Goldba
- Page 13 and 14: Int J Ped Oto, Feb 1998, 43(1):73
- Page 15 and 16: Mashikian MV, Stollerman GH. Vaccin
- Page 17 and 18: Wu T, Wang SL, Xiang YZ. Study on t
- Page 19 and 20: Prevots DR, Ciofi degli Atti ML, Sa
- Page 21 and 22: Del Giudice G, Pizza M, Rappuoli R.
- Page 23 and 24: Huber S, Kappos L, Fuhr P, Wetzel S
- Page 25 and 26: Ngui SL, Hallet R, Teo CG. Natural
- Page 27 and 28: Thomson J, Hilditch A, Pirkis J, Du
- Page 29 and 30: Belloni C, Pistorio A, Tinelli C, K
- Page 31 and 32: DanielRibeiro CT. Is there a role
- Page 33 and 34: Gallup, R. The MMR question [letter
- Page 35 and 36: Hull BP, McIntyre PB. A reevaluat
- Page 37 and 38: Lieu TA, Ray GT, Black SB, Butler J
- Page 39 and 40: Mulholland K. Evaluation of vaccine
- Page 41 and 42: Rudolph, K. M., Parkinson, A. J., R
- Page 43 and 44: Taylor JA, Newman RD. Parental atti
- Page 45: Bonaccorsi G, Papini D, Bonanni P,
- Page 49 and 50: Mortimer, E. A. Jr, Ball, R., Ball,
- Page 51 and 52: Taranger, J., Trollfors, B., Bergfo
- Page 53 and 54: Christensen, L. S., Scholler, S., S
- Page 55 and 56: Khanal, P. Nepal's Childhood Mortal
- Page 57 and 58: Poland GA, Jacobson RM, Vierkant RA
- Page 59 and 60: Vyse, A. J., Gay, N. J., White, J.
- Page 61 and 62: Brodkin, H. Economic Analysis of In
- Page 63 and 64: Freed, G. L., Davis, M. M., and Cla
- Page 65 and 66: Karlsen, T. H.; Sommerfelt, H.; Klo
- Page 67 and 68: NascimentoCarvalho, C. M.; Moreno
- Page 69 and 70: Skegg, D. C. Autism and MeaslesMu
- Page 71 and 72: Wharton, M., Strikas, R. A., Harpaz
- Page 73 and 74: Boyce, T. G.; Weaver, A. L.; St Sau
- Page 75 and 76: D'Heilly, S. J.; Nichol, K. L. Work
- Page 77 and 78: Guy, B.; Chanthavanich, P.; Gimenez
- Page 79 and 80: Koca, R.; Altinyazar, H. C.; Numano
- Page 81 and 82: Modlin, J. F. Poliomyelitis in the
- Page 83 and 84: Roost, H. P.; Gassner, M.; Grize, L
- Page 85 and 86: Vazquez, M.; LaRussa, P. S.; Gersho
- Page 87 and 88: Beaujean, D. J.; Verweij, M. F.; va
- Page 89 and 90: Desjeux, G.; GaloisyGuibal, L.; C
- Page 91 and 92: Gust, D.; Brown, C.; Sheedy, K.; Hi
- Page 93 and 94: Koch, D.; Thompson, L.; Swart, B. L
- Page 95 and 96: Newport, M. J.; Goetghebuer, T.; Ma
- Page 97 and 98:
Satcher, D. Adult Immunization Disp
- Page 99 and 100:
Timmermans, D. R.; Henneman, L.; Hi
- Page 101 and 102:
Aaby, P.; Jensen, H.; Walraven, G.
- Page 103 and 104:
Carrat, F.; Lavenu, A.; Cauchemez,
- Page 105 and 106:
Emanuel, E. J.; Wertheimer, A. Publ
- Page 107 and 108:
Halperin, S. A.; Sweet, L.; Baxenda
- Page 109 and 110:
Klote, M. M.; Engler, R. J.; Martin
- Page 111 and 112:
Mitka, M. Age Range Widens for Pert
- Page 113 and 114:
Pool, V.; Iskander, J. Safety of In
- Page 115 and 116:
Skowronski, D. M.; Woolcott, J. C.;
- Page 117 and 118:
Vu, D. M.; Kelly, D.; Heath, P. T.;
- Page 119 and 120:
Approved: New Requirement Allowing
- Page 121 and 122:
Caldwell, S. J.; Hayney, M. S. Prop
- Page 123 and 124:
Dempsey, A. F. Vaccination Against
- Page 125 and 126:
Galvani, A. P.; Reluga, T. C.; Chap
- Page 127 and 128:
Influenza Vaccination Coverage Amon
- Page 129 and 130:
Lawrence, S. J.; Lottenbach, K. R.;
- Page 131 and 132:
Monath, T. P. Yellow Fever As an En
- Page 133 and 134:
Patrick, D. Prevention Strategies:
- Page 135 and 136:
Scheiblhofer, S.; Weiss, R.; Thalha
- Page 137 and 138:
Takada, T.; Yamashita, T.; Sato, M.
- Page 139 and 140:
Winston, C. A.; Mims, A. D.; Leathe
- Page 141 and 142:
Bechtol, Z. Launching a Community
- Page 143 and 144:
Chumakov, K.; Ehrenfeld, E. Vaccine
- Page 145 and 146:
Dylag, A. M.; Shah, S. I. Administr
- Page 147 and 148:
GomezdeLeon, P.; DiazGarcia,
- Page 149 and 150:
Jackson, L. A.; Starkovich, P.; Dun
- Page 151 and 152:
Kusuhara, K.; Ohga, S.; Hoshina, T.
- Page 153 and 154:
Madjid, M. Acute Infections, Vaccin
- Page 155 and 156:
Naghipour, M.; Nakagomi, T.; Nakago
- Page 157 and 158:
Pool, R.; Mushi, A.; Armstrong, Sch
- Page 159 and 160:
Savidan, E.; Chevat, C.; Marsh, G.
- Page 161 and 162:
Strauman, T. J.; Coe, C. L.; McCrud
- Page 163 and 164:
Vien, N. C.; Feroldi, E.; Lang, J.
- Page 165 and 166:
Akmatov, M. K.; Mikolajczyk, R. T.;
- Page 167 and 168:
Braillon, A. A New French Paradox:
- Page 169 and 170:
Daley, M. F.; Curtis, C. R.; Pyrzan
- Page 171 and 172:
Flu Campaign Receives Excellence Aw
- Page 173 and 174:
Holvast, A.; van, Assen S.; de, Haa
- Page 175 and 176:
Kisakye, A.; Makumbi, I.; Nansera,
- Page 177 and 178:
Makidon, P. E.; Nigavekar, S. S.; B
- Page 179 and 180:
Niu, M.; Ball, R. Adverse Events Af
- Page 181 and 182:
Primus, L. Improving Influenza Vacc
- Page 183 and 184:
Schwartz, B.; Orenstein, W. A. Prio
- Page 185 and 186:
Tharmaphornpilas, P.; Yoocharean, P
- Page 187 and 188:
Weiskopf, D.; Weinberger, B.; Grube